Bio-Rad Laboratories, Inc. reports results for the quarter ended June 30 - Earnings Summary

Bio-Rad Laboratories

04/08/2026 23:43

Bio-Rad Laboratories, Inc. BIO.N reported quarterly adjusted earnings of $2.62​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $2.61.  The mean expectation of five analysts for the quarter was for earnings of $1.75 per share. Wall Street expected results to range from $1.54  to $2.05 per share.
Revenue fell 0.1% to $651.00 million from a year ago; analysts expected $623.99 million. 
Bio-Rad Laboratories, Inc.'s reported EPS for the quarter was $13.85​.
The company reported quarterly net income of $371.4 million.
Bio-Rad Laboratories, Inc. shares had risen by 14.0% this quarter and gained 10.5% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 4.8% in the last three months.​ 
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy," 3 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is  "buy."
Wall Street's median 12-month price target for Bio Rad Laboratories Inc is $310.00, about 7.4% below its last closing price of $332.88
This summary was machine generated from LSEG data August 4 at 10:43 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
1.75
2.62
Beat
Mar. 31 2026 
1.98
1.89
Missed
Dec. 31 2025 
2.70
2.51
Missed
Sep. 30 2025 
1.93
2.26
Beat